S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CYCCP Cyclacel Pharmaceuticals Inc

6.61

0.00 (0.00%)

Pre Market

Last Updated: 18:00:00

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

Cyclacel Pharmaceuticals (NASDAQ:CYCCP)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Cyclacel Pharmaceuticals Charts.

Cyclacel Pharmaceuticals (NASDAQ:CYCCP)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Cyclacel Pharmaceuticals Charts.

Cyclacel Pharmaceuticals Inc News

Form 8-K - Current report
Friday 15 November 2024 (4 days ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (4 days ago) • Edgar (US Regulatory)

Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds
Thursday 14 November 2024 (5 days ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (5 days ago) • Edgar (US Regulatory)

Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds
Wednesday 13 November 2024 (6 days ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (6 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (6 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (7 days ago) • Edgar (US Regulatory)

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
Tuesday 12 November 2024 (7 days ago) • GlobeNewswire Inc.

Form RW - Registration Withdrawal Request
Thursday 7 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 24 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule
Thursday 24 October 2024 (4 weeks ago) • GlobeNewswire Inc.

More Cyclacel Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions